Bristol Myers Squibb Reports Fatal Event in Autoimmune CAR-T Trial

By Ed Silverman · STAT News · 2026-10-26

According to STAT News, a patient enrolled in a Phase 1 study for multiple sclerosis died after receiving an experimental cell therapy from Bristol Myers Squibb. The individual developed septic pneumonia following complications that included unresolved motor symptoms and the admi

According to STAT News, a patient enrolled in a Phase 1 study for multiple sclerosis died after receiving an experimental cell therapy from Bristol Myers Squibb. The individual developed septic pneumonia following complications that included unresolved motor symptoms and the admi